BEMPEGALDESLEUKIN for Sarcoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 6 adverse event reports in the FDA FAERS database where BEMPEGALDESLEUKIN was used for Sarcoma.
Most Reported Side Effects for BEMPEGALDESLEUKIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Acute kidney injury | 9 | 5.2% | 1 | 8 |
| Cerebrovascular accident | 9 | 5.2% | 1 | 9 |
| Hypotension | 9 | 5.2% | 0 | 9 |
| Atrial fibrillation | 7 | 4.0% | 0 | 6 |
| Pyrexia | 7 | 4.0% | 1 | 7 |
| Malignant neoplasm progression | 6 | 3.5% | 4 | 5 |
| Eosinophilia | 5 | 2.9% | 0 | 5 |
| Pulmonary embolism | 5 | 2.9% | 2 | 5 |
Other Indications for BEMPEGALDESLEUKIN
Renal cell carcinoma (45)
Malignant melanoma (30)
Transitional cell carcinoma (26)
Non-small cell lung cancer (13)
Metastatic renal cell carcinoma (6)
Metastatic malignant melanoma (5)
Triple negative breast cancer (5)
Other Drugs Used for Sarcoma
DOXORUBICIN (409)
PAZOPANIB (296)
IFOSFAMIDE (280)
EPIRUBICIN (132)
NIVOLUMAB (124)
VINCRISTINE (105)
CYCLOPHOSPHAMIDE (79)
ETOPOSIDE (75)
TRABECTEDIN (75)
TRONOXAL INYECTABLE (74)